TNDM 241220 32.00C (TNDM241220C32000) Stock Options, News & Quotes

US OptionsDetailed Quotes

TNDM241220C32000

Watchlist

1.68
-0.12-6.67%

15min DelayClose Nov 22 16:00 ET

1.68High1.68Low

Intraday

5D
Daily

News

Tandem Diabetes Care Announces Upcoming Conference Presentations
BusinesswireNov 21 16:05 ET
Morgan Stanley Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $45
Moomoo NewsNov 11 08:31 ET · Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Waters (WAT), Pharvaris (PHVS) and Tandem Diabetes Care (TNDM)
TipRanksNov 11 08:21 ET · Ratings
Assessing MedTech Impact From Potential China Tariffs
Seeking AlphaNov 9 11:28 ET
Barclays Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Raises Target Price to $60
Moomoo NewsNov 9 03:33 ET · Ratings
A Quick Look at Today's Ratings for Tandem Diabetes Care(TNDM.US), With a Forecast Between $40 to $75
Moomoo NewsNov 8 08:00 ET · Ratings

Comments

mad541

Aug 2 11:48

company needs money this always drops 35% after earnings I'm out

mad541

Aug 2 11:46

$Tandem Diabetes Care (TNDM.US)$ company needs money this always drops 35% after earnings I'm out 🩸🩸🩸

Trytosaveabit

Aug 1 15:13

Update

$Tandem Diabetes Care (TNDM.US)$ Second Quarter 2024 Highlights
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...

70862468

May 21 11:11

Stock moves

$Tandem Diabetes Care (TNDM.US)$
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!

Moomoo AI

Mar 22 05:56

Despite losses and negative cash flow, the company's US$178.2m balance sheet allows for at least two years of growth spending. However, the stock is seen as risky due to these financial conditions.

Is Tandem Diabetes Care (NASDAQ:TNDM) Using Debt In A Risky Way?